By Saadia Aslam Despite an upsurge in the incidence of atherosclerotic cardiovascular diseases (ASCVD) among young adults, the attributable risk of recreational substance use among…
View More Recreational substances associated with a higher likelihood of premature atherosclerotic cardiovascular disease
By Ahmed El-Medany In contrast to their prevalence in the overall disease population, Black individuals were considerably underrepresented in trials that affirmed the United States’…
View More Underrepresentation of black participants in key Cardiology trials
In this Swiss case-crossover study, Saucy et al. investigate the potential acute effects of aircraft noise on mortality and the specific role of different night-time…
View More Does night-time aircraft noise trigger mortality? A case-crossover study on 24,886 cardiovascular deaths
The American College of Cardiology (ACC) and the American Heart Association (AHA) ended 2020 by publishing updated guidance on the management of valvular heart disease. This document covered significant ground with regards to transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair.
View More 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
The National Institute for Health and Care Excellence (NICE) has today published a report highlighting progress made by the health and care system in implementing…
View More NICE report on the impact cardiovascular disease management
“Even before the COVID-19 pandemic, air pollution was an issue of growing concern due to its impact on people’s health, although it was frequently overlooked…
View More Leading cardiovascular organisations call for urgent action to reduce air pollution
Dr Amit Bhan examines a study on Novel Oral Anticoagulants recently published in the European Heart Journal.
View More Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44,000 patients
Important data from Brazil demonstrating the safety and non inferiority of DOAC therapy in biological mitral valves and atrial fibrillation. This study makes a significant…
View More Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
Imperial College have published an innovative study in the BCS demonstrating that adverse symptom related to statin, placebo or no treatment. The study design was…
View More N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
Statement following a Medical Device Alert issued by the MHRA
View More Enhanced Follow Up for Patients with Trifecta Aortic Valve Bioprostheses: A Statement from BHVS, SCTS and BCS